Published by Frank Prenesti on 25th May 2021
(Sharecast News) - Britain's Competition and Markets Authority (CMA) said it is looking into AstraZeneca's $39bn acquisition of America's Alexion Pharmaceuticals over concerns the deal could harm competition in the UK.
URL: http://www.digitallook.com/dl/news/story/31870756/...